COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

Gossamer Bio Shares Plummet as Lung Disease Drug Fails Late-stage Trial

Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug...

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

7 Pulmonology Headlines You Missed in January 2026

7 Pulmonology Headlines You Missed in January 2026

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

Treat Early, Treat Hard: Redefining the Modern PAH Treatment Paradigm Victoria Johnson

Pulmonary arterial hypertension treatment continues to evolve with new therapies and strategies.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Latest News

Gossamer Bio's experimental treatment failed to significantly improve exercise capacity in patients with a rare ⁠lung condition in a late-stage study, knocking the drug...

VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial

7 Pulmonology Headlines You Missed in January 2026

Elevated BDNF Linked to Depressive Symptoms in Patients with Asthma, With Hiroshi Iwamoto, MD, PhD

COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD

Pulmonary arterial hypertension treatment continues to evolve with new therapies and strategies.

News All Time

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma

Sleep Disorders Linked to Poorer Symptom Control in Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Getting Through the Door: How COPD, Lung Cancer Screening Remains Minimal

Advancing NP and PA Involvement in Pulmonary Care, CHEST Learning Susan Corbridge, PhD, Alanna Kavanugh, MSN, CCRN

Susan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.

Thunderstorms Linked to Surge in Asthma ER Visits

Thunderstorms Linked to Surge in Asthma ER Visits

House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma

House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma

5 Pulmonology Headlines You Missed in November 2025

5 Pulmonology Headlines You Missed in November 2025

Recommended News For You

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

High resolution ultrasound could enable faster prostate cancer diagnosis

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.

Breast cancer prevention: How nurse practitioners and physician assistants can help

Treatment of Smoldering Myeloma Cuts Progression Rate in Half

Ketamine plus psychotherapy for "excellent" PTSD

Recommended Articles For You

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System 

Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown 

Hemoglobin C: Understanding its Role in Sickle Cell Disease 

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

2.

Australian researchers attribute drop in melanoma rates to increasingly diverse population

3.

CAR T cells improve patients' quality of life: a study

4.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

5.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

1.

Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025

2.

Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health

3.

Unlocking the Mysteries of ICD 10 Code Normocytic Anemia

4.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

5.

Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

3.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

4.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot